| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
We help healthcare organizations grow intelligently. Our technology enables deeper connections with consumers and physicians through more complete information and the tools to reach them. Payers & Providers can now thrive in the evolving healthcare landscape. Tea Leaves merger with Everyday Health, Inc., created a powerful marketing, communications and growth solution for health systems. Tea Leaves Health’s strategic growth platform, coupled with Everyday Health’s content, audience, data, and expertise in sales and marketing, provides a robust solution for hospital systems to drive their strategic marketing objectives. The combination of Tea Leaves technology and Everyday Health, Inc.’s capabilities creates a powerful tool for hospital systems to reach high-value consumers, positively affect physician relationships and strategically grow health systems through deepening relationships that drive their business.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.
Wound Care Innovations is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospicom is a Cold Spring, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SNBL USA is a part of the SNBL Group of companies and is a subsidiary of Shin Nippon Biomedical Laboratories (SNBL). As part of the SNBL Group, SNBL USA shares the corporate mission statement: We are committed to freeing patients from suffering by